文献速递乳腺乳腺X线

不同分子亚型乳腺癌在数字乳腺断层摄影上的影像特征:与乳腺癌检出率的关系

Imaging features of breast cancers on digital breast tomosynthesis according to molecular subtype: association with breast cancer detection.
PubMed 文献 · Br J Radiol · 2017-10-09

该研究回顾了288例浸润性乳腺癌的数字乳腺断层摄影(DBT)表现,按BI-RADS术语分析不同分子亚型的影像特征,并由3名读者独立盲法阅片量化检出情况。结果显示不同分子亚型的DBT影像特征存在差异(p < 0.001),但分子亚型不影响DBT对乳腺癌的检出(p = 0.213),检出率受肿瘤大小、乳腺密度及肿块或钙化存在的影响。

要点

  • HR阳性癌多表现为不规则毛刺状肿块,HER2阳性癌多为细小多形性或线样分支状钙化,三阴性癌多为边缘清晰的不规则肿块(p < 0.001)。
  • DBT对乳腺癌的检出率在不同分子亚型间无显著差异(p = 0.213)。
  • 肿瘤大小、乳腺密度及肿块或钙化的存在影响DBT检出,而非分子亚型。

核心结论

  • 不同分子亚型乳腺癌在DBT上呈现不同的影像特征,但分子亚型不影响DBT对乳腺癌的检出。

研究设计与样本

  • 经机构审查委员会批准并豁免知情同意的研究,回顾分析288例浸润性乳腺癌的DBT表现,按BI-RADS术语判读,并由读者(0-3名)独立盲法阅片量化检出。

关键影像表现/征象

  • HR阳性癌最常见的DBT表现为不规则毛刺状肿块。
  • HER2阳性癌最常见的DBT表现为细小多形性或线样分支状钙化。
  • 三阴性乳腺癌最常见的DBT表现为边缘清晰的不规则肿块。

诊断标准与关键数值

  • 不同分子亚型间DBT影像特征比较,p < 0.001。
  • 不同分子亚型间DBT乳腺癌检出评分比较,p = 0.213,无显著差异。

临床应用与阅片要点

  • 阅片时可根据分子亚型预判DBT上可能的影像表现,但分子亚型不影响检出率,检出仍受肿瘤大小、乳腺密度及肿块或钙化存在的影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate imaging features of breast cancers on digital breast tomosynthesis (DBT) according to molecular subtype and to determine whether the molecular subtype affects breast cancer detection on DBT.

METHODS: This was an institutional review board--approved study with a waiver of informed consent. DBT findings of 288 invasive breast cancers were reviewed according to Breast Imaging Reporting and Data System lexicon. Detectability of breast cancer was quantified by the number of readers (0-3) who correctly detected the cancer in an independent blinded review. DBT features and the cancer detectability score according to molecular subtype were compared using Fisher's exact test and analysis of variance.

RESULTS: Of 288 invasive cancers, 194 were hormone receptor (HR)-positive, 48 were human epidermal growth factor receptor 2 (HER2) positive and 46 were triple negative breast cancers. The most common DBT findings were irregular spiculated masses for HR-positive cancer, fine pleomorphic or linear branching calcifications for HER2 positive cancer and irregular masses with circumscribed margins for triple negative breast cancers (p < 0.001). Cancer detectability on DBT was not significantly different according to molecular subtype (p = 0.213) but rather affected by tumour size, breast density and presence of mass or calcifications.

CONCLUSION: Breast cancers showed different imaging features according to molecular subtype; however, it did not affect the cancer detectability on DBT. Advances in knowledge: DBT showed characteristic imaging features of breast cancers according to molecular subtype. However, cancer detectability on DBT was not affected by molecular subtype of breast cancers.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Lee SH, Chang JM, Shin SU, et al. Imaging features of breast cancers on digital breast tomosynthesis according to molecular subtype: association with breast cancer detection. Br J Radiol. 2017. PMID: 28937263. doi:10.1259/bjr.20170470

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。